Investment Director, Cambridge Investment Capital
Dr Michael Anstey is an Investment Director specialising in healthcare investments.
Before joining CIChe was a Principal in the Healthcare Practice Area at The Boston Consulting Group’s (BCG) Toronto office. Michael has experience in advising multinational healthcare businesses across North America, Europe, India, and Japan on a broad range of topics, including corporate strategy, sales and marketing, market access, R&D strategy, and M&A.
Michael was also co-founder and COO of an early stage biotechnology company focused on developing small molecule drugs that target protein-protein interactions implicated in disease.
Prior toBCG, Michael worked in venture capital, where he focused on investing in early stagehealthcare and life science businesses.
Michael earned his DPhil in Zoology in the field of neurobiology, jointly supervised by professors at the University of Cambridge and the University of Oxford.
Michael sits on the board of Bicycle Therapeutics, Congenica and Storm Therapeutics.
(+44) 1223 496 000
Babraham Bioscience Technologies Ltd
Babraham Research Campus
CB22 3AT, United Kingdom
01223 813 557